![Martin Lange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Lange
Teknisk/Vetenskaplig/F&U Direktör på
NOVO NORDISK A/S
Profil
Martin Holst Lange is Director at Pharmacosmos A since 2023.
Dr. Lange is Chief Scientific Officer & Executive VP at Novo Nordisk A since 2002.
Formerly, Dr. Lange was Medical Director at Novo Nordisk, Inc. from 2006 to 2008.
Dr. Lange was Director at Beta Bionics, Inc. from 2017 to 2020.
Education includes two doctorates from the University of Copenhagen, conferred in 1997 and 2004.
Aktiva positioner av Martin Lange
| Företag | Position | Start |
|---|---|---|
| NOVO NORDISK A/S | Teknisk/Vetenskaplig/F&U Direktör | 2025-08-07 |
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Direktör/Styrelseledamot | 2023-08-18 |
Tidigare kända positioner av Martin Lange
| Företag | Position | Slut |
|---|---|---|
| BETA BIONICS, INC. | Direktör/Styrelseledamot | 2020-02-20 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Teknisk/Vetenskaplig/F&U Direktör | 2008-01-01 |
Martin Langes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
79
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
